000 03092nam a22004817a 4500
008 201006s20202020 xxu||||| |||| 00| 0 eng d
022 _a2045-2322
024 _a10.1038/s41598-020-72511-8 [doi]
024 _a10.1038/s41598-020-72511-8 [pii]
040 _aOvid MEDLINE(R)
099 _a32973266
245 _aBurn resuscitation strategy influences the gut microbiota-liver axis in swine.
251 _aScientific Reports. 10(1):15655, 2020 09 24.
252 _aSci. rep.. 10(1):15655, 2020 09 24.
252 _zSci. rep.. 10(1):15655, 2020 Sep 24.
253 _aScientific reports
260 _c2020
260 _fFY2021
265 _sepublish
265 _sepublish
266 _d2020-10-06
268 _aScientific Reports. 10(1):15655, 2020 Sep 24.
520 _aFluid resuscitation improves clinical outcomes of burn patients; however, its execution in resource-poor environments may have to be amended with limited-volume strategies. Liver dysfunction is common in burn patients and gut dysbiosis is an understudied aspect of burn sequelae. Here, the swine gut microbiota and liver transcripts were investigated to determine the impact of standard-of-care modified Brooke (MB), limited-volume colloid (LV-Co), and limited-volume crystalloid (LV-Cr) resuscitation on the gut microbiota, and to evaluate its' potential relationship with liver dysfunction. Independent of resuscitation strategy, bacterial diversity was reduced 24 h post-injury, and remained perturbed at 48 h. Changes in community structure were most pronounced with LV-Co, and correlated with biomarkers of hepatocellular damage. Hierarchical clustering revealed a group of samples that was suggestive of dysbiosis, and LV-Co increased the risk of association with this group. Compared with MB, LV-Co and LV-Cr significantly altered cellular stress and ATP pathways, and gene expression of these perturbed pathways was correlated with major dysbiosis-associated bacteria. Taken together, LV-Co resuscitation exacerbated the loss of bacterial diversity and increased the risk of dysbiosis. Moreover, we present evidence of a linkage between liver (dys)function and the gut microbiota in the acute setting of burn injury.
546 _aEnglish
650 _a*Burns/mi [Microbiology]
650 _a*Burns/th [Therapy]
650 _a*Gastrointestinal Microbiome
650 _a*Liver/pp [Physiopathology]
650 _aAnimals
650 _aBurns/me [Metabolism]
650 _aBurns/pp [Physiopathology]
650 _aDysbiosis/co [Complications]
650 _aGene Expression Regulation
650 _aLiver/me [Metabolism]
650 _aSwine
651 _aMedStar Health Research Institute
656 _aFirefighters' Burn and Surgical Research Laboratory
657 _aJournal Article
700 _aShupp, Jeffrey W
790 _aBurmeister DM, Bynum JA, Chung KK, Dubick MA, Gomez BI, Granados JC, Muraoka WT, Nicholson SE, Shupp JW
856 _uhttps://dx.doi.org/10.1038/s41598-020-72511-8
_zhttps://dx.doi.org/10.1038/s41598-020-72511-8
942 _cART
_dArticle
999 _c5614
_d5614